T-cell and Transcriptomic Responses to Prime-boost Strategies of 3 HIV Vaccines(MVA HIV-B; LIPO-5; GTU-MultiHIV B)-ANRS/INSERM VRI01 Trial

Laura Richert (1, 2) , Aurelie Wiedemann (3) , Odile Launay (4) , Frederic Lucht (3) , Isabelle Poizot-Martin (3) , Christine Lacabaratz (3) , Hakim Hocini (3) , Edouard Lhomme (1, 2) , Claire Bauduin (5) , Mathieu Surenaud (3) , Lydia Guillaumat (3) , Cécile Lefebvre (3) , Lucile Hardel (2) , Véronique Rieux (3) , Solenne Delahaye (3) , Elodie Rouch (2) , Kalevi Reijonen (6) , Yves Levy (3) , Rodolphe Thiébaut (1, 2) , Jean-Daniel Lelievre (3)

1 SISTM - Statistics In System biology and Translational Medicine
2 BPH - Bordeaux population health
3 VRI - Vaccine Research Institute [Créteil, France]
4 CIC 1417 - CIC Cochin Pasteur
5 CHU Bordeaux
6 FIT Biotech Ltd. [Tampere]

Mots clés: SISTM; MORPH3Eus

Domaines: Santé publique et épidémiologie

Laura Richert, Aurelie Wiedemann, Odile Launay, Frederic Lucht, Isabelle Poizot-Martin, et al.. T-cell and Transcriptomic Responses to Prime-boost Strategies of 3 HIV Vaccines(MVA HIV-B; LIPO-5; GTU-MultiHIV B)-ANRS/INSERM VRI01 Trial. AIDS Research and Human Retroviruses, 2018, pp.16-16. ⟨hal-03160938⟩